Anti e cadherin

The experimental cells of the same growth time and good condition were collected. After washing with ice‐cold PBS, cells were added to the RIPA lysis buffer for 20 minutes. After centrifuged (13 188 g) with 4°C, protein was determined using a BCA protein assay kit. Western blotting was carried out according to standard protocol. The positive stripe was analyzed by Gel Pro 4.0 optical density analysis software (Media Cybernetics, Rockville, MD, USA), and the accumulated optical density reference value of integrated optical density was measured. The following antibodies were used in this study: anti‐INHBB (ab69286; Abcam, Cambridge, UK), anti‐E‐cadherin (YT1454; ImmunoWay, Plano, TX, USA), anti‐vimentin (YT4880; ImmunoWay), anti‐VEGF‐A (YT5108; ImmunoWay), anti‐MMP‐9 (YT1892; ImmunoWay), anti‐Smad2/3 (YT4332; ImmunoWay), anti‐Smad4 (YT4337; ImmunoWay), anti‐p‐Smad2/3(T8) (YP0362; ImmunoWay), anti‐TGF‐β1 (YT4632; ImmunoWay), anti‐β‐actin (20270; ProMab, Richmond, CA, USA), anti‐p53 (10442‐1‐AP; Proteintech, Rosemont, IL, USA).

Cells were treated with a series concentrations of Huaier (0, 5, 10 and 15mg/ml) for 24h, and then lysed by cell lysis buffer for Western and IP (Beyotime, P0013). Protein concentration was detected with BCA Protein Assay Kit (KeyGen BioTECH, KGP902). After that, 20µg proteins were separated by 10% or 12% SDS-PAGE and transferred onto Pure Nitrocellulose Blotting Membrane (Pall Corporation, P/N 66485). Then, the blots were blocked for nonspecific binding with 5% non-fat milk in PBST (PBS, Tween-20, pH7.4) at room temperature for 1h. Next, the blots were incubated overnight at 4℃ with 5% non-fat milk containing primary antibodies which are listed as follows: anti-PCNA (ImmunoWay, YM3031), anti-Ki-67 (ImmunoWay, YT2467), anti-β-actin (ImmunoWay, YM3028), anti-Bcl-2 (ImmunoWay, YM3041), anti-Bax (ImmunoWay, YT0455), anti-E-cadherin (ImmunoWay, YT1454), anti-N-cadherin (ImmunoWay, YT2988), anti-YAP1 (abcam, ab52771), anti-p-YAP1 (ab76252), anti-CyclinD1 (abcam, ab134175), anti-Cleaved Caspase Substrate Motif (Cell Signaling, #8698) and anti-YAP/TAZ (Cell Signaling, #8418). After that, incubating blots with secondary antibodies conjugated with HRP (Cell Signaling, #7074 or #7076) for 1h at room temperature. Finally, after washing three times with PBST, the blots were visualized by New Super ECL Assay (KeyGen BioTECH, KGP1128).